ZAVZPRET (ZAVEGEPANT)
ZAVZPRET (ZAVEGEPANT) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ZAVZPRET; Generic name: ZAVEGEPANT; Manufacturer: U.S. Pharmaceuticals.
| Brand name | ZAVZPRET |
|---|---|
| Generic name | ZAVEGEPANT |
| Manufacturer | U.S. Pharmaceuticals |
| Used for | 1 INDICATIONS AND USAGE ZAVZPRET is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use ZAVZPRET is not indicated for the preventive treatment of migraine. ZAVZPRET is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use ZAVZPRET is not indicated for the preventive treatment of migraine. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • The recommended dose is 10 mg given as a single spray in one nostril, as needed. ( 2.1 ) • The maximum dose in a 24-hour period is 10 mg (one spray). ( 2.1 ) • The safety of treating more than 8 migraines in a 30-day period has not been established. ( 2.1 ) 2.1 Dosing Information The recommended dose of ZAVZPRET is 10 mg given as a single spray in one nostril, as needed. The maximum dose that may be given in a 24-hour period is 10 mg (one spray). The safety of treat |
| Active ingredient(s) | ZAVEGEPANT HYDROCHLORIDE |
| Route | NASAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1191475f-e999-49f4-a805-93ad08596b1b |